Clinical trial
PreFER Managed Ventricular Pacing (MVP) For Elective Replacement
NCT00293241 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Completed
Key facts
| NCT number | NCT00293241 |
|---|---|
| Title | PreFER Managed Ventricular Pacing (MVP) For Elective Replacement |
| Official title | PreFER MVP for Elective Replacement |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases |
| Intervention type | Device |
| Interventions | Managed Ventricular Pacing programmed ON/OFF |
| Enrollment | 630 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Feb 17, 2006 |
| Last update posted | Jun 24, 2016 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: